−737.6DKK
−26.05 MDKK
25.82 K
About ORPHAZYME A/S
Sector
CEO
Jakob Færch Bendtsen
Headquarters
Copenhagen
Website
Employees (FY)
1
Founded
2009
ISIN
DK0062502894
FIGI
BBG00J25X0C4
Orphazyme A/S is a biopharmaceutical company, which engages in the research and development of treatments for rare diseases. It provides Arimoclomol program and molecular entities program. The company was founded by Anders Morkeberg Hinsby, Marja Jaattela, Martin Rahbek Kornum, and Thomas Kirkegaard Jensen in 2009 and is headquartered in Copenhagen, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ORPHA is 1047.0 DKK — it has decreased by 4.80% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange ORPHAZYME A/S stocks are traded under the ticker ORPHA.
ORPHAZYME A/S is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
ORPHA stock is 13.11% volatile and has beta coefficient of −0.70. Check out the list of the most volatile stocks — is ORPHAZYME A/S there?
ORPHA earnings for the last quarter are −12.15 K DKK per share, whereas the estimation was −15.45 K DKK resulting in a 21.38% surprise. The estimated earnings for the next quarter are −13.26 K DKK per share. See more details about ORPHAZYME A/S earnings.
Yes, you can track ORPHAZYME A/S financials in yearly and quarterly reports right on TradingView.
ORPHA stock has risen by 5.64% compared to the previous week, the month change is a 10.51% fall, over the last year ORPHAZYME A/S has showed a 30.87% increase.
ORPHA net income for the last quarter is −13.26 M DKK, while the quarter before that showed −12.78 M DKK of net income which accounts for −3.75% change. Track more ORPHAZYME A/S financial stats to get the full picture.
Today ORPHAZYME A/S has the market capitalization of 38.84 M, it has decreased by 2.89% over the last week.
No, ORPHA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ORPHA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORPHAZYME A/S stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.00 employees. See our rating of the largest employees — is ORPHAZYME A/S on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORPHAZYME A/S technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORPHAZYME A/S stock shows the sell signal. See more of ORPHAZYME A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.